Intrathecal Corticosteroid Therapy. Predictors of response
Intrathecal Corticosteroid Therapy. Predictors of response
https://www.frontiersin.org/articles/10 ... 00132/full
Objective: The autoimmune disease Multiple Sclerosis (MS) represents a heterogeneous disease pattern with an individual course that may lead to permanent disability. In addition to immuno-modulating therapies patients benefit from symptomatic approaches like intrathecal corticosteroid therapy (ICT), which is frequently applied in a growing number of centers in Germany. ICT reduces spasticity, which elongates patient's walking distance and speed, thus improves quality of life.
Methods: In our study we set out to investigate cerebrospinal fluid (CSF) parameters and clinical predictors for response to ICT. Therefore, we analyzed 811 CSF samples collected from 354 patients over a time period of 12 years. Patients who received ICT were divided in two groups (improving or active group) depending on their EDSS-progress. As control groups we analyzed data of ICT naïve patients, who were divided in the two groups as well. Additionally we observed the clinical progress after receiving ICT by comparison of patients in both groups.
Results: The results showed clinical data had a significant influence on the probability to benefit from ICT. The probability (shown by Odds Ratio of 1.77–2.43) to belong to the improving group in contrast to the active group is significantly (p < 0.0001) higher at later stages of disease with early disease onset (<35 years, OR = 2.43) and higher EDSS at timepoint of ICT-initiation (EDSS > 6, OR = 2.06). Additionally, we observed lower CSF cell counts (6.68 ± 1.37 μl) and lower total CSF protein (412 ± 18.25 mg/l) of patients who responded to ICT compared to patients who did not (p < 0.05). In the control group no significant differences were revealed. Furthermore analyses of our data revealed patients belonging to the improving group reach an EDSS of 6 after ICT-initiation less often than patients of the active group (after 13 years 39.8% in the improving group, 67.8% in the active group).
Conclusion: Our study implies two relevant messages: (i) although the study was not designed to prospectively assess clinical data, in this cohort no severe side effects were observed under ICT; (ii) disease onset, EDSS, CSF cell count, and total protein may serve as predictive markers for therapy response.
-
- Similar Topics
- Replies
- Views
- Last post
-
-
Response to Copaxone can be predicted
by frodo » Thu Nov 07, 2019 7:11 am » in Chronic Cerebrospinal Venous Insufficiency (CCSVI) - 0 Replies
- 87 Views
-
Last post by frodo
Thu Nov 07, 2019 7:11 am
-
-
-
Biomarker for response to interferon
by frodo » Tue Jan 22, 2019 4:28 am » in MS Etiology and Pathogenesis - 0 Replies
- 212 Views
-
Last post by frodo
Tue Jan 22, 2019 4:28 am
-
-
- 0 Replies
- 578 Views
-
Last post by frodo
Thu May 16, 2019 8:09 am
-
-
Biomarkers. Response to Fingolimod can be predicted.
by frodo » Thu Apr 19, 2018 12:31 pm » in MS Etiology and Pathogenesis - 0 Replies
- 701 Views
-
Last post by frodo
Thu Apr 19, 2018 12:31 pm
-
-
-
Biomarkers: Response to Glatiramer Acetate predictable
by frodo » Sun Jul 22, 2018 10:26 am » in MS Etiology and Pathogenesis - 0 Replies
- 725 Views
-
Last post by frodo
Sun Jul 22, 2018 10:26 am
-
-
-
Biomarkers. Gadolinium predicts response to medication
by frodo » Mon Mar 26, 2018 12:33 pm » in MS Etiology and Pathogenesis - 0 Replies
- 839 Views
-
Last post by frodo
Mon Mar 26, 2018 12:33 pm
-
-
-
Heterogeneity: CSF profile predicts response to interferons
by frodo » Wed Jul 04, 2018 3:58 am » in MS Etiology and Pathogenesis - 0 Replies
- 770 Views
-
Last post by frodo
Wed Jul 04, 2018 3:58 am
-
-
-
Personalized medicine: Prediction of natalizumab response
by frodo » Tue May 28, 2019 6:29 am » in MS Etiology and Pathogenesis - 0 Replies
- 190 Views
-
Last post by frodo
Tue May 28, 2019 6:29 am
-
-
-
T-cell analysis predicts response to Natalizumab
by frodo » Thu Sep 05, 2019 6:39 am » in MS Etiology and Pathogenesis - 0 Replies
- 105 Views
-
Last post by frodo
Thu Sep 05, 2019 6:39 am
-